The level of PD-L1 expression has been associated with that of glucose transporter 1 (Glut1) and hypoxia-inducible factor 1α (HIF-1α) in patients with NSCLC [12, 13]. This evidence concerns the gene HIF1A and non-small cell lung carcinoma.